HDAC-targeting epigenetic modulators for cancer immunotherapy

Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges

Recent advances of molecular mechanisms of regulating PD-L1 expression in melanoma

CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib